Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Lowe

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Endocrine-Related Cancer|March 25, 2000
Activation of p53 by oncogenesS W Lowe
Nature Medicine|June 1, 1997
Progress of the smart bomb cancer virusS W Lowe
Current Opinion in Oncology|November 1, 1995
Cancer therapy and p53S W Lowe
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteinsA V Samuelson, S W Lowe
Nature Genetics|December 2, 2000
p53 and p73: seeing double?M S Soengas, S W Lowe
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Apoptosis is critical for drug response in vivoC A Schmitt, S W Lowe
Blood Cells, Molecules & Diseases|May 19, 2001
Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivoC A Schmitt, S W Lowe
Methods in Cell Biology|June 9, 2001
Methods for studying pro- and antiapoptotic genes in nonimmortal cellsM E McCurrach, S W Lowe
Genes & Development|April 1, 1993
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosisS W Lowe, H E Ruley
Cell Death and Differentiation|May 20, 2006
The p53-Bcl-2 connectionM T Hemann, S W Lowe
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Endocrine-Related Cancer|March 25, 2000
Activation of p53 by oncogenesS W Lowe
Nature Medicine|June 1, 1997
Progress of the smart bomb cancer virusS W Lowe
Current Opinion in Oncology|November 1, 1995
Cancer therapy and p53S W Lowe
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteinsA V Samuelson, S W Lowe
Nature Genetics|December 2, 2000
p53 and p73: seeing double?M S Soengas, S W Lowe
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Apoptosis is critical for drug response in vivoC A Schmitt, S W Lowe
Blood Cells, Molecules & Diseases|May 19, 2001
Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivoC A Schmitt, S W Lowe
Methods in Cell Biology|June 9, 2001
Methods for studying pro- and antiapoptotic genes in nonimmortal cellsM E McCurrach, S W Lowe
Genes & Development|April 1, 1993
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosisS W Lowe, H E Ruley
Cell Death and Differentiation|May 20, 2006
The p53-Bcl-2 connectionM T Hemann, S W Lowe
Pageof 7